Your session is about to expire
← Back to Search
Cryotherapy
Open label for Chronic Rhinitis (SNIF Trial)
N/A
Waitlist Available
Led By Amber U Luong, MD, PhD
Research Sponsored by Arrinex, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow-up visit at 3 months post treatment
Awards & highlights
Summary
A multi-center, prospective, non-randomized, observational registry to asses the results of the ClariFix(TM) device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis.
Eligible Conditions
- Chronic Rhinitis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ follow-up visit at 3 months post treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~follow-up visit at 3 months post treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline in nasal symptom severity
Secondary outcome measures
Clinician-assessed improvement in nasal symptoms
Patient-assessed improvement in nasal symptoms
Trial Design
1Treatment groups
Experimental Treatment
Group I: Open labelExperimental Treatment1 Intervention
Open label registry study of patients treated with the ClariFix device for chronic rhinitis.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ClariFix
2018
N/A
~390
Find a Location
Who is running the clinical trial?
Arrinex, Inc.Lead Sponsor
3 Previous Clinical Trials
157 Total Patients Enrolled
2 Trials studying Chronic Rhinitis
130 Patients Enrolled for Chronic Rhinitis
Amber U Luong, MD, PhDPrincipal InvestigatorUT Health - The University of Texas
1 Previous Clinical Trials
22 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger